Andrew R. Miksztal
Keine laufenden Positionen mehr
Profil
Andrew R.
Miksztal worked as an Associate Director-Pharmaceutical Analysis at Oread Laboratories, Inc. from 1996 to 2000.
Prior to that, he worked as a Scientist-Preformulation & Pharmaceutical Analysis at Syntex Corp.
from 1987 to 1995.
He also worked as a Senior Scientist-Pharmaceutical Research at Roche Palo Alto LLC in 1995 and 1996.
Dr. Miksztal earned a doctorate degree from Rutgers State University of New Jersey.
Ehemalige bekannte Positionen von Andrew R. Miksztal
| Unternehmen | Position | Ende |
|---|---|---|
| Oread Laboratories, Inc. | Corporate Officer/Principal | 01.01.2000 |
Roche Palo Alto LLC
 Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1996 |
| Syntex Corp. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1995 |
Ausbildung von Andrew R. Miksztal
| Rutgers State University of New Jersey | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
| Oread Laboratories, Inc. | |
Roche Palo Alto LLC
Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Health Technology |
| Syntex Corp. | Health Technology |
